Condition
Recurrent Astrocytoma, IDH-Mutant, Grade 3 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent Astrocytoma, IDH-Mutant, Grade 3 clinical trials that are recruiting, in United States. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Adding triapine to radiation therapy for recurrent glioblastoma and astrocytoma
This early-phase study tests whether giving the drug triapine together with radiation is safe and tolerable for adults whose glioblastoma or astrocytoma has come back.
-
Using genetically modified immune cells to treat recurrent brain tumors
This study is testing a new treatment using modified immune cells to see if it can help people with recurring brain tumors feel better and fight their cancer.
Related topics
Quick answers
How many Recurrent Astrocytoma, IDH-Mutant, Grade 3 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.